Join the 'Carboplatin' group to help and get support from people like you. How it works
Carboplatin Blog
| Tweet |
Drug Combo Might Fight Aggressive Breast Cancer More Safely
Posted 5 Oct 2011 by Drugs.com
WEDNESDAY, Oct. 5 – Treating women with an aggressive form of early stage breast cancer using Herceptin and chemotherapy, while not turning to a third type of drug known as an anthracycline, improves survival while posing less danger to the heart, researchers report. They tested three different regimens, one of which did not include any anthracyclines. When Herceptin is given with doxorubicin (Adriamycin), an anthracycline, toxic cardiac effects have been seen. "What the study shows is you have comparable effectiveness in a Herceptin-based regimen when you don't use the anthracyclines," said Dr. Dennis Slamon, director of clinical and translational research at the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles. Earlier research of his led to the development of Herceptin (trastuzumab). He contends that the new regimen should be the new standard of care, ... Read more
Related support groups: Breast Cancer, Herceptin, Carboplatin, Taxotere, Adriamycin, Doxorubicin, Adriamycin PFS, Carboplatin Novaplus, Paraplatin, Docetaxel, Adriamycin RDF, Docefrez
Cancer Patients Should Ask Doctors to Use Simple Terms
Posted 28 Sep 2011 by Drugs.com
WEDNESDAY, Sept. 28 – Cancer patients are often faced with many difficult-to-understand treatment choices that can have serious side effects and even mean the difference between life and death. That's why it's crucial that patients insist doctors use plain language in explaining the options, advised Angela Fagerlin, an associate professor of internal medicine at the University of Michigan Medical School and a researcher at the U-M Comprehensive Cancer Center. "People are making life and death decisions that may affect their survival and they need to know what they're getting themselves into. Cancer treatments and tests can be serious. Patients need to know what kind of side effects they might experience as a result of the treatment they undergo," Fagerlin said in a university news release. She and her colleagues outlined a number of tips to help patients get the information they need ... Read more
Related support groups: Cancer, Methotrexate, Provera, Breast Cancer, Lupron, Accutane, Depo-Provera, Prostate Cancer, Tamoxifen, Femara, Arimidex, Lupron Depot, Medroxyprogesterone, Claravis, Gleevec
Elderly Lung Cancer Patients Can Gain From Two-Drug Chemo: Study
Posted 9 Aug 2011 by Drugs.com
MONDAY, Aug. 8 – Countering conventional wisdom, researchers in France say that elderly lung cancer patients can gain significant benefit from an aggressive, double-barreled chemotherapy that's often used in younger patients. The finding raises questions about standard public health recommendations, such as those issued the American Society of Clinical Oncology in 2004, which advised physicians not to expose elderly patients with non-small cell lung cancer (NSCLC) to the undesirable side effects of combination chemotherapy. Instead, older patients have typically been offered less harsh – but also less effective – chemotherapies containing a single agent. That's because, until now, it's been assumed that the benefits to elderly patients of dual-chemo ("doublet") regimens simply weren't worth their onerous side effects and risks. But, "our study demonstrates clearly that [the doublet] ... Read more
Related support groups: Lung Cancer, Carboplatin, Gemzar, Gemcitabine, Taxol, Paclitaxel, Vinorelbine, Navelbine, Onxol, Carboplatin Novaplus, Paraplatin
Ask a Question
Further Information
Related Condition Support Groups
Cancer, Ovarian Cancer, Cervical Cancer
Related Drug Support Groups
Carboplatin Novaplus, Paraplatin